Stay updated on Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial

Sign up to get notified when there's something new on the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new site revision 3.4.3 adds Oversight and Study Status entries, replacing the previous revision 3.4.2.
    Difference
    0.5%
    Check dated 2026-03-12T19:45:21.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now shows revision: v3.4.2 in place of v3.4.1. This is a minor metadata update.
    Difference
    0.1%
    Check dated 2026-02-12T01:57:19.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision history shows a new entry v3.4.1 added and the previous v3.4.0 removed; this reflects a minor version-control update with no visible changes to study data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:55:59.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The history page adds a Show glossary option and clarifies color-coded changes; the revision label was updated from v3.3.4 to v3.4.0.
    Difference
    0.8%
    Check dated 2026-01-28T21:43:45.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    A new revision entry v3.3.4 was added to the record history, and the previous entry v3.3.3 was removed.
    Difference
    0.1%
    Check dated 2026-01-14T04:12:11.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Revision history shows the addition of Revision: v3.3.3 and the removal of HHS Vulnerability Disclosure as well as Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T22:40:57.000Z thumbnail image

Stay in the know with updates to Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page.